Di bawah ada daftar dengan kolom dan profil perusahaan yang subyeknya berkaitan.

Berita Hari Ini KAEF

  • Kimia Farma will Construct Indonesia's First Pharmaceutical Salt Factory

    Indonesian state-controlled pharmaceutical company Kimia Farma will construct Indonesia's first pharmaceutical salt factory in Jombang (East Java) in an attempt to supply the domestic market and curb imports of this type of salt. Minister of State-Owned Enterprises Dahlan Iskan said that the plant can commence operations near the end of 2014 and will have an annual production capacity of 2,000 tons of pharmaceutical salt (approximately two thirds of domestic demand).

    Lanjut baca ›

Artikel Terbaru KAEF

  • How Big Indonesian Pharmaceutical Firms Cope with Rupiah Weakness

    How the Big Indonesian Pharmaceutical Firms Cope with Rupiah Weakness

    One of the national industries that is heavily affected by the weak rupiah exchange rate is Indonesia's pharmaceutical industry. Considering around 90 percent of raw materials in the pharmaceutical industry need to be imported from abroad (in US dollars), production costs rise sharply in times of significant rupiah depreciation. It is estimated that materials imported from abroad account for about 75 percent of pharmaceutical companies' total production costs.

    Lanjut baca ›

  • Indonesian Pharmaceutical Companies in Focus: Kimia Farma

    Indonesian Pharmaceutical Companies in Focus: Kimia Farma

    State-controlled pharmaceutical company Kimia Farma is expected to show steadily improving corporate earnings in the years ahead supported by Indonesia's universal healthcare scheme (in Indonesian: Jaminan Kesehatan Nasional or JKN) that was implemented by the social security agency Badan Penyelenggara Jaminan Sosial Kesehatan (BPJS) in early 2014. The scheme aims to provide all Indonesian citizens with access to a wide range of health services. Obviously, local pharmaceutical companies are in a great position to benefit from this program.

    Lanjut baca ›

Bisnis Terkait KAEF